Improving antibiotic use in the hospital: Focusing on positive blood cultures is an effective option

Presse Medicale

Volumn 40, Issue 6, 2011, Pages

  Lesprit, Philippe ^a   Merabet, Lilia ^a   Fernandez, José ^a   Legrand, Patrick ^a   Brun Buisson, Christian ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG USE; ENTEROBACTERIACEAE; FOLLOW UP; FUNGUS; HUMAN; MEDICAL SPECIALIST; MICROBIAL CONTAMINATION; NONHUMAN; PATIENT COUNSELING; PSEUDOMONAS AERUGINOSA; SPECIES DISTRIBUTION; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; TREATMENT PLANNING; WARD;

EID: 79957667081     PISSN: 07554982     EISSN: 07554982     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.12.014     Document Type: Article

References (15)

1. Setia U., Gross P.A. Bacteremia in a community hospital: spectrum and mortality. Arch Intern Med 1977, 137:1698-1701.
2. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997, 24:584-602.
3. Weinstein M.P. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 2003, 41:2275-2278.
4. Cunha B.A. Empiric antimicrobial therapy for bacteremia: get it right from the start or get a call from infectious disease. Clin Infect Dis 2004, 39:1170-1173.
5. Cunney R.J., McNamara E.B., Alansari N., Loo B., Smyth E.G. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteremia. J Clin Pathol 1997, 50:1010-1012.
6. Rintala E., Kairisto V., Eerola E., Nikoskelainen J., Lehtonen O. Antimicrobial therapy of septicemic patients in intensive care units before and after blood culture reporting. Scand J Infect Dis 1991, 23:341-346.
7. Byl B., Clevenbergh P., Jacobs F., Struelens M.J., Zech F., Kentos A., et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999, 29:60-66.
8. Fluckiger U., Zimmerli W., Sax H., Frei R., Widmer A.F. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis 2000, 19:493-500.
9. Fowler V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27:478-486.
10. Lesprit P., Duong T., Girou E., Hemery F., Brun-Buisson C. Impact of a computer-generated alert system prompting review of antibiotic use in hospitals. J Antimicrob Chemother 2009, 63:1058-1063.
11. Bouza E., Sousa D., Munoz P., Rodriguez-Creixems M., Fron C., Lechuz J.G. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis 2004, 39:1161-1169.
12. Ispahani P., Pearson N.J., Greenwood D. An analysis of community and hospital-acquired bacteremia in a large hospital in the United Kingdom. Q J Med 1987, 63:427-440.
13. Nathwani D., Davey P., France A.J., Phillips G., Orange G., Parratt D. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. Q J Med 1996, 89:789-797.
14. Delitt T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P., et al. Infectious Disease Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177.
15. Washington J.A.D., Ilstrup D.M. Blood cultures: issues and controversies. Rev Infect Dis 1986, 8:792-802.